Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Biol Chem ; 287(52): 43665-73, 2012 Dec 21.
Article in English | MEDLINE | ID: mdl-23091050

ABSTRACT

Myocardial constitutive No production depends on the activity of both endothelial and neuronal NOS (eNOS and nNOS, respectively). Stimulation of myocardial ß(3)-adrenergic receptor (ß(3)-AR) produces a negative inotropic effect that is dependent on eNOS. We evaluated whether nNOS also plays a role in ß(3)-AR signaling and found that the ß(3)-AR-mediated reduction in cell shortening and [Ca(2+)](i) transient amplitude was abolished both in eNOS(-/-) and nNOS(-/-) left ventricular (LV) myocytes and in wild type LV myocytes after nNOS inhibition with S-methyl-L-thiocitrulline. LV superoxide (O(2)(·-)) production was increased in nNOS(-/-) mice and reduced by L-N(ω)-nitroarginine methyl ester (L-NAME), indicating uncoupling of eNOS activity. eNOS S-glutathionylation and Ser-1177 phosphorylation were significantly increased in nNOS(-/-) myocytes, whereas myocardial tetrahydrobiopterin, eNOS Thr-495 phosphorylation, and arginase activity did not differ between genotypes. Although inhibitors of xanthine oxidoreductase (XOR) or NOX2 NADPH oxidase caused a similar reduction in myocardial O(2)(·-), only XOR inhibition reduced eNOS S-glutathionylation and Ser-1177 phosphorylation and restored both eNOS coupled activity and the negative inotropic and [Ca(2+)](i) transient response to ß(3)-AR stimulation in nNOS(-/-) mice. In summary, our data show that increased O(2)(·-) production by XOR selectively uncouples eNOS activity and abolishes the negative inotropic effect of ß(3)-AR stimulation in nNOS(-/-) myocytes. These findings provide unequivocal evidence of a functional interaction between the myocardial constitutive NOS isoforms and indicate that aspects of the myocardial phenotype of nNOS(-/-) mice result from disruption of eNOS signaling.


Subject(s)
Calcium Signaling/physiology , Muscle Proteins/metabolism , Myocardium/enzymology , Myocytes, Cardiac/enzymology , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type I/metabolism , Animals , Arginase/genetics , Arginase/metabolism , Calcium Signaling/drug effects , Citrulline/analogs & derivatives , Citrulline/pharmacology , Enzyme Inhibitors/pharmacology , Heart Ventricles/cytology , Heart Ventricles/enzymology , Isoenzymes/antagonists & inhibitors , Isoenzymes/genetics , Isoenzymes/metabolism , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Mice, Knockout , Muscle Proteins/antagonists & inhibitors , Muscle Proteins/genetics , Myocardium/cytology , Myocytes, Cardiac/cytology , NADPH Oxidase 2 , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/genetics , Phosphorylation/drug effects , Phosphorylation/physiology , Receptors, Adrenergic, beta-3/genetics , Receptors, Adrenergic, beta-3/immunology , Superoxides/metabolism , Thiourea/analogs & derivatives , Thiourea/pharmacology , Xanthine Dehydrogenase/genetics , Xanthine Dehydrogenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL